EMC To Announce Third-Quarter Financial Results On October 21
News Release To Be Available On www.EMC.com
Get Alerts EMC Hot Sheet
Join SI Premium – FREE
HOPKINTON, Mass., Oct. 7, 2015 /PRNewswire/ -- EMC Corporation (NYSE: EMC) will publish its third-quarter 2015 financial results on October 21, 2015 at approximately 7:00 a.m. ET. EMC will also issue an advisory news release on October 21, 2015 announcing availability of the results via the EMC Investor Relations (http://www.emc.com/ir) and the U.S. Securities and Exchange Commission (http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000790070&owner=exclude&count=40) websites.
EMC will hold a conference call for investors at 8:30 a.m. ET to review the financial results. A live webcast of the call will be available on the EMC Investor Relations website.
Connect With EMC
- Download the EMC Investor Relations App here
- Connect with EMC on Twitter (@EMCCorp and @EMC_News), LinkedIn, Facebook and SocialSphere
About EMC EMC Corporation is a global leader in enabling businesses and service providers to transform their operations and deliver IT as a service. Fundamental to this transformation is cloud computing. Through innovative products and services, EMC accelerates the journey to cloud computing, helping IT departments to store, manage, protect and analyze their most valuable asset – information – in a more agile, trusted and cost-efficient way. Additional information about EMC can be found at www.EMC.com.
EMC is a registered trademark of EMC Corporation in the United States and/or other countries. All other trademarks used are the property of their respective owners.
Logo - http://photos.prnewswire.com/prnh/20120606/NE19788LOGO-a
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/emc-to-announce-third-quarter-financial-results-on-october-21-300156040.html
SOURCE EMC Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Creatd files Form S-1 and reports Q1 2026 financial results
- Silexion gets German approval for pancreatic cancer trial of SIL204
- DiaMedica doses first patients in Phase 2 fetal growth restriction trial
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share